Hematology status update: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 61: Line 61:
*
*
*[[Purpura]]
*[[Purpura]]
** Papular (SP)
** Papular  
** Infectious (SP)
** Infectious  
**[[Purpura fulminans]]
**[[Purpura fulminans]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 73: Line 73:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
**
**
**
*[[Thrombotic micropangiopathies]]  
**
*[[Thrombotic micropangiopathies]] (LP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 84: Line 82:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[opangiopathies]] (LP)
*[[opangiopathies]]  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 101: Line 99:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Neutrophilia]] (SP)
*[[Neutrophilia]]  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 110: Line 108:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Neutropenia]] (SP)
*[[Neutropenia]]  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 119: Line 117:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Lymphocytosis]] (SP)
*[[Lymphocytosis]]  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 128: Line 126:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Monocytosis]] (SP)
*[[Monocytosis]]  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 137: Line 135:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Eosiniphilia]] (SP)
*[[Eosiniphilia]]  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |

Revision as of 16:52, 3 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.

System Leader: Ramyar Ghandriz, M.D.

List of Chapters Requiring Content

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Hematology
Acute megakaryoblastic leukemia

In progress chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Hematology Hemophilia Assigned Muhammad Adnan Heider Abdelrahman

Assigned Ayushi Jane Ramyar
Assigned Asra Firdous Ramyar
Assigned Anum Dilip Homa

Completed chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Hematology Alpha thalassemia
Retrieved from "https://www.wikidoc.org/index.php?title=Hematology_status_update&oldid=1621123"